|
Q
|
Emca1
|
Estrogen-induced mammary cancer QTL 1
|
|
IAGP
|
| |
4.4
|
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr 5:99,216,724...148,607,142
|
|
Q
|
Emca11
|
Estrogen-induced mammary cancer QTL 11
|
|
IDA
|
| |
|
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:99,753,548...113,061,097
|
|
Q
|
Emca12
|
Estrogen-induced mammary cancer QTL 12
|
|
IDA
|
| |
|
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:124,160,767...133,749,643
|
|
Q
|
Emca13
|
Estrogen-induced mammary cancer QTL 13
|
|
IDA
|
| |
|
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:9,823,266...99,753,708
|
|
Q
|
Emca2
|
Estrogen-induced mammary cancer QTL 2
|
|
IAGP
|
| |
1.6
|
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr18:18,007,599...63,571,040
|
|
Q
|
Emca4
|
Estrogen-induced mammary cancer QTL 4
|
susceptibility
|
IDA
|
| |
3.7
|
estrogen induced
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 7:62,004,452...101,773,158
|
|
Q
|
Emca5
|
Estrogen-induced mammary cancer QTL 5
|
susceptibility
|
IDA
|
| |
3.9
|
estrogen induced
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 3:43,827,364...169,034,231
|
|
Q
|
Emca6
|
Estrogen-induced mammary cancer QTL 6
|
susceptibility
|
IDA
|
| |
5.8
|
estrogen induced
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 4:44,463,720...155,883,716
|
|
Q
|
Emca7
|
Estrogen-induced mammary cancer QTL 7
|
|
IDA
|
| |
4.0
|
estrogen induced
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 6:15,107,216...107,351,382
|
|
Q
|
Emca8
|
Estrogen-induced mammary cancer QTL 8
|
susceptibility
|
IDA
|
| |
4.1
|
estrogen induced
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 5:50,328,551...141,643,988
|
|
Q
|
Mamtr5
|
Mammary tumor resistance QTL 5
|
|
IDA
|
| |
|
|
RGD |
PMID:17230524 |
RGD:1599390 |
NCBI chr 5:18,873,947...63,873,947
|
|
Q
|
Mamtr6
|
Mammary tumor resistance QTL 6
|
|
IDA
|
| |
|
|
RGD |
PMID:17230524 |
RGD:1599390 |
NCBI chr18:19,278,901...83,218,561
|
|
Q
|
Mamtr7
|
Mammary tumor resistance QTL 7
|
|
IDA
|
| 0.003 |
|
|
RGD |
PMID:19052818 |
RGD:2302423 |
NCBI chr10:9,658,275...104,670,812
|
|
Q
|
Mamtr8
|
Mammary tumor resistance QTL 8
|
|
IDA
|
| 0.001 |
|
|
RGD |
PMID:19052818 |
RGD:2302423 |
NCBI chr18:31,359,408...83,218,561
|
|
Q
|
Mcs1
|
Mammary carcinoma susceptibility QTL 1
|
|
QTM
|
| |
4.4
|
|
RGD |
PMID:8168109 |
RGD:61080 |
NCBI chr 2:7,887,772...23,319,447
|
|
Q
|
Mcs15
|
Mammary carcinoma susceptibility QTL 15
|
|
IAGP
|
| |
4.5
|
|
RGD |
PMID:16568087 |
RGD:1581951 |
NCBI chr10:85,565,469...103,884,409
|
|
Q
|
Mcs16
|
Mammary carcinoma susceptibility QTL 16
|
|
IDA
|
| |
2.4
|
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 1:2,244,390...43,433,040
|
|
Q
|
Mcs17
|
Mammary carcinoma susceptibility QTL 17
|
|
IDA
|
| |
3.0
|
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 1:197,670,404...242,670,404
|
|
Q
|
Mcs18
|
Mammary carcinoma susceptibility QTL 18
|
|
IDA
|
| |
2.6
|
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 2:7,887,772...42,804,738
|
|
Q
|
Mcs19
|
Mammary carcinoma susceptibility QTL 19
|
|
IDA
|
| |
2.5
|
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 5:99,485,997...103,690,167
|
|
Q
|
Mcs2
|
Mammary carcinoma susceptibility QTL 2
|
|
QTM
|
| |
3.38
|
|
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 7:19,032,807...35,526,300
|
|
Q
|
Mcs20
|
Mammary carcinoma susceptibility QTL 20
|
|
IDA
|
| |
3.0
|
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 9:13,533,770...42,791,750
|
|
Q
|
Mcs21
|
Mammary carcinoma susceptibility QTL 21
|
|
IDA
|
| |
3.0
|
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr10:28,875,650...52,200,160
|
|
Q
|
Mcs22
|
Mammary carcinoma susceptibility QTL 22
|
|
IDA
|
| |
3.3
|
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr18:52,539,763...63,933,058
|
|
Q
|
Mcs23
|
Mammary carcinoma susceptibility QTL 23
|
|
IDA
|
| |
|
|
RGD |
PMID:17404222 |
RGD:1601189 |
|
|
Q
|
Mcs24
|
Mammary carcinoma susceptibility QTL 24
|
|
IDA
|
| |
|
|
RGD |
PMID:17404222 |
RGD:1601189 |
NCBI chr 5:64,719,390...109,719,390
|
|
Q
|
Mcs26
|
Mammary carcinoma susceptibility QTL 26
|
|
IDA
|
| 1.0E-4 |
|
DMBA induced
|
RGD |
PMID:20737482 |
RGD:4143380 |
NCBI chr 6:106,752,656...132,339,866
|
|
Q
|
Mcs27
|
Mammary carcinoma susceptibility QTL 27
|
|
IDA
|
| 1.0E-4 |
|
DMBA induced
|
RGD |
PMID:20737482 |
RGD:4143380 |
NCBI chr13:43,437,904...47,841,255
|
|
Q
|
Mcs3
|
Mammary carcinoma susceptibility QTL 3
|
|
QTM
|
| |
2.15
|
|
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 1:102,268,556...147,268,556
|
|
Q
|
Mcs4
|
Mammary carcinoma susceptibility QTL 4
|
|
QTM
|
| |
1.1
|
|
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 8:16,290,444...61,290,444
|
|
Q
|
Mcs5
|
Mammary carcinoma susceptibility QTL 5
|
|
QTM
|
| |
10.51
|
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 5:55,805,606...132,207,589
|
|
Q
|
Mcs6
|
Mammary carcinoma susceptibility QTL 6
|
|
QTM
|
| |
2.29
|
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 7:26,737,401...63,902,784
|
|
Q
|
Mcs7
|
Mammary carcinoma susceptibility QTL 7
|
|
QTM
|
| |
2.38
|
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr10:72,224,939...107,211,142
|
|
Q
|
Mcs8
|
Mammary carcinoma susceptibility QTL 8
|
|
QTM
|
| |
4.28
|
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr14:3,813,074...24,531,477
|
|
Q
|
Mcsm1
|
Mammary carcinoma susceptibility modifier QTL 1
|
|
QTM
|
| |
|
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 6:58,632,962...103,632,962
|
|
|
Q
|
Mcs29
|
Mammary carcinoma susceptibility QTL 29
|
|
IDA
|
| |
|
|
RGD |
PMID:21205740 |
RGD:5684388 |
NCBI chr 5:77,816,155...77,988,860
|
|
Q
|
Mcs30
|
Mammary carcinoma susceptibility QTL 30
|
|
IDA
|
| |
8.62
|
|
RGD |
PMID:24023717 |
RGD:7327193 |
NCBI chr12:797,729...8,525,593
|
|
Q
|
Mcs31
|
Mammary carcinoma susceptibility QTL 31
|
|
IDA
|
| |
2.98
|
|
RGD |
PMID:23967281 |
RGD:7794780 |
NCBI chr 9:77,813,894...111,552,878
|
|
Q
|
Mcs32
|
Mammary carcinoma susceptibility QTL 32
|
|
IDA
|
| |
2.61
|
|
RGD |
PMID:23967281 |
RGD:7794780 |
NCBI chr 1:115,540,693...238,914,717
|
|
Q
|
Mcs33
|
Mammary carcinoma susceptibility QTL 33
|
|
IDA
|
| |
1.93
|
|
RGD |
PMID:23967281 |
RGD:7794780 |
NCBI chr 5:131,345,754...166,875,058
|
|
Q
|
Mcs34
|
Mammary carcinoma susceptibility QTL 34
|
|
IDA
|
| |
1.54
|
|
RGD |
PMID:23967281 |
RGD:7794780 |
|
|